Dipharma Group is a global CDMO and a leading manufacturer of APIs and Intermediates for generic and contract manufacturing markets, offering about 40 APIs with DMFs lodged worldwide, with more than 500 skilled and highly committed employees, 4 cGMP plants, located in the U.S.A. and Italy, plus commercial sales offices in Italy, the U.S.A. and China.